Prelude Capital Management’s Immunomedics Inc IMMU Stock Holding History

Prelude Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-133,613	Closed	-$11.4M	–	2273
2020 Q3	$11.4M	Buy	133,613 +113,090	+551%	+$5.72M	0.55%	26
2020 Q2	$727K	Buy	+20,523	New	+$600K	0.04%	391
2018 Q3	–	Sell	-7,680	Closed	-$182K	–	2175
2018 Q2	$182K	Buy	+7,680	New	+$154K	0.01%	775
2017 Q4	–	Sell	-261	Closed	-$3.08K	–	1862
2017 Q3	$4K	Buy	+261	New	+$2.6K	﹤0.01%	1531

Prelude Capital Management's IMMU Position: Q4 2020 in Review

Prelude Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 133,613 shares — an estimated $11.4M sold.

Prelude Capital Management first reported a position in IMMU in Q3 2017 and held it in 4 quarters. The position peaked at $11.4M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Prelude Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Prelude Capital Management sold 133,613 Immunomedics Inc shares in Q4 2020, an estimated $11.4M.
Prelude Capital Management first reported a position in Immunomedics Inc in Q3 2017 and held it in 4 quarters.
Prelude Capital Management's Immunomedics Inc position peaked at $11.4M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Prelude Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.